We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$325B
AUM Growth
+$19.8B
Cap. Flow
+$3.2B
Cap. Flow %
0.99%
Top 10 Hldgs %
12.37%
Holding
6,814
New
216
Increased
2,666
Reduced
3,277
Closed
152

Sector Composition

Rank Sector Weight
1 Financials 9.69%
2 Technology 9.44%
3 Healthcare 8.03%
4 Consumer Discretionary 7.35%
5 Communication Services 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCS
6151
ACCESS Newswire
ACCS
$25.7M
$5K ﹤0.01%
500
-1,800
-78% -$17.8K
ALPN
6152
DELISTED
Alpine Immune Sciences Inc
ALPN
$5K ﹤0.01%
461
-638
-58% -$6.46K
PLXP
6153
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$5K ﹤0.01%
473
-30
-6% -$326
GSV
6154
DELISTED
Gold Standard Ventures Corp.
GSV
$5K ﹤0.01%
2,425
SPE.PRB
6155
DELISTED
Special Opportunities Fund, Inc. 3.50% Convertible Preferred Stock, Series B
SPE.PRB
$5K ﹤0.01%
+212
New +$5.42K
YMLI
6156
DELISTED
VanEck Vectors High Income Infrastructure MLP ETF
YMLI
$5K ﹤0.01%
300
RYAM.PRA
6157
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
$5K ﹤0.01%
50
PBSK
6158
DELISTED
Poage Bankshares, Inc.
PBSK
$5K ﹤0.01%
246
+101
+70% +$1.98K
SNMX
6159
DELISTED
Senomyx, Inc.
SNMX
$5K ﹤0.01%
5,300
-21,208
-80% -$23.4K
ELON
6160
DELISTED
Echelon Corp
ELON
$5K ﹤0.01%
750
GLBR
6161
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$5K ﹤0.01%
1,822
-10,682
-85% -$46.4K
BSTG
6162
DELISTED
Biostage, Inc. Common Stock
BSTG
$5K ﹤0.01%
13,631
+7,726
+131% +$4.23K
ALR.PRB
6163
DELISTED
Alere Inc
ALR.PRB
$5K ﹤0.01%
15
BAA
6164
DELISTED
Banro Corporation Common Stock
BAA
$5K ﹤0.01%
4,606
WINT
6165
DELISTED
Windtree Therapeutics Inc
WINT
$5K ﹤0.01%
3,999
-31
-0.8% -$40
TEAR
6166
DELISTED
TearLab Corporation
TEAR
$5K ﹤0.01%
1,701
GFN
6167
DELISTED
General Finance Corporation
GFN
$5K ﹤0.01%
+900
New +$4.65K
HDMV icon
6168
First Trust Horizon Managed Volatility Developed International ETF
HDMV
$17.5M
$4K ﹤0.01%
+142
New +$4.16K
IBIO icon
6169
iBio
IBIO
$70.5M
$4K ﹤0.01%
2
IZEA icon
6170
IZEA Worldwide
IZEA
$58.3M
$4K ﹤0.01%
250
LGMK
6171
DELISTED
LogicMark
LGMK
-1
Closed -$11.5K
PSTV icon
6172
Plus Therapeutics
PSTV
$25.3M
0
RDCM icon
6173
Radcom
RDCM
$171M
$4K ﹤0.01%
+200
New +$3.72K
RELL icon
6174
Richardson Electronics
RELL
$267M
$4K ﹤0.01%
+600
New +$3.67K
FLNA
6175
Filana Therapeutics
FLNA
$48.3M
$4K ﹤0.01%
584

Similar funds

Morgan Stanley's Q1 2017 Portfolio in Review

As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.

  • Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
  • Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
  • Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
  • Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
  • Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
  • Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.